It usually starts at around three in the morning. You are awake, the sheets are damp, and you are running through a list of likely culprits. Too much coffee. A stressful quarter at work. That second glass of wine. Menopause rarely makes the list first, and when it finally does, most women keep the thought to themselves.
That silence is the real problem. Women talk openly about fertility, mental load, burnout and skincare. Hormonal change touches sleep, mood, memory, joints and libido all at once. Yet it still gets handled in whispers, or not at all. This guide is here to make the talk easier. It starts with the option that raises the most questions and the most confusion: bioidentical hormone therapy, often shortened to BHRT.
Why the Silence Costs More Than Comfort
Most of us assume hot flashes arrive, hang around for a season, then politely leave. The data says otherwise. The Study of Women’s Health Across the Nation tracked thousands of women through the transition. Its 2015 report in JAMA Internal Medicine found that frequent hot flashes and night sweats lasted a median of 7.4 years. They carried on for a median of 4.5 years after the last period. For some groups of women, the figure stretched past a decade.
Seven years is not a phase. It is a stretch of life that overlaps with career peaks, teenagers and aging parents. Many women spend the first two or three of those years quietly troubleshooting their own bodies. Nobody says the word perimenopause out loud.
Part of the hesitation is historical. News coverage in the early 2000s left a generation sure that any hormone treatment was risky. That message stuck far longer than the science behind it. Medical bodies have since revisited the picture. On November 10, 2025, the Society of Obstetricians and Gynaecologists of Canada restated its guideline position. Menopausal hormone therapy is the most effective option for hot flashes and night sweats. It can be safely started in women without contraindications who are younger than 60, or less than 10 years past menopause. Programs that offer bioidentical hormone therapy build their intake around that same window. It is why timing comes up at the first visit rather than the fifth.
What “Bioidentical” Actually Means
The word sounds like marketing, and it is often used that way. In medicine it has a narrow and useful meaning. A bioidentical hormone has the same structure as the one your own ovaries make. Estradiol is estradiol, whether your body made it or a lab did. The same holds for micronized progesterone.
Here is the part that surprises people. Bioidentical does not have to mean custom-mixed. Many of these hormones already come as approved products with set doses. Skin patches and gels deliver estradiol. Capsules deliver micronized progesterone. The Canadian Menopause Society’s Pocket Guide to Menopause Management does not call one route best for everyone. It does name a patch or gel as the preferred route for certain groups. Those include smokers, and women with migraine, high triglycerides, metabolic syndrome, high blood pressure or diabetes. The same goes for women at raised risk of a blood clot. Where the uterus needs protecting, it pairs that route with micronized progesterone.
The truly different category is custom-compounded therapy. A pharmacy mixes it to order for one patient. In 2020, the National Academies of Sciences, Engineering, and Medicine reviewed the evidence on these products. It found they lack the safety and efficacy data that approved products carry. The report advised keeping them for two narrow cases. One is a documented allergy to an ingredient in an approved product. The other is a documented need for a dose form that is not made as an approved one. It also said patient preference alone is not a reason to pick them. The Menopause Society draws the same line in its patient guidance.
A Quick Comparison
| Approved bioidentical products | Custom-compounded preparations | |
| Molecular structure | Identical to your own hormones | Identical to your own hormones |
| Dose consistency | Standardized and batch-tested | Varies between batches and pharmacies |
| Regulatory review | Checked for safety, quality and efficacy | Not reviewed by Health Canada or the FDA |
| Evidence base | Studied in clinical trials | Limited published outcome data |
| Typical forms | Patches, gels, capsules, vaginal preparations | Creams, troches, pellets, custom blends |
| Guideline position | Recommended first, where suitable | Reserved for specific clinical situations |
Some clinicians pitch compounded hormones as safer or more natural than approved ones. The current evidence does not back that up. It is a fair thing to question, politely, in the room.
Who Tends to Be a Candidate
No single profile fits everyone. Candidacy is a clinical decision that rests on your history and your labs. Still, hormone therapy comes up more often when several of these apply:
- Hot flashes or night sweats that disrupt sleep or daily function
- You are under 60, or less than 10 years past your final period
- Vaginal dryness, discomfort during sex, or repeated urinary symptoms. On their own, these are usually treated with low-dose vaginal estrogen rather than whole-body therapy
- Early or surgical menopause, where longer treatment is frequently advised
- Elevated fracture risk alongside bothersome symptoms
- No unexplained vaginal bleeding, no breast or other estrogen-driven cancer, no acute liver trouble, no heart disease, no past stroke, and no history of blood clots
That last point matters. The list above is the short version, not the whole of it. Anyone with those conditions needs a different conversation. A careful provider will say so early rather than late. Non-hormonal options exist too, and the range has widened in the past few years.
Five Questions Worth Bringing to Your First Appointment
A little preparation changes the whole visit. These five tend to draw out the most useful answers:
- Given my history, am I inside the window where hormone therapy is usually favoured? This anchors the talk in timing, not just in how bad the symptoms feel.
- Are you suggesting an approved product or a compounded one, and why? A clear clinical reason is fine. Vague talk about being more natural is not.
- If I still have a uterus, what is protecting the lining of it? Estrogen without enough progesterone is a known risk. The answer should be specific.
- What are we measuring, and when do we check again? Symptom notes, bloodwork and follow-up dates should be set before you start.
- What would make us stop or change course? Knowing the exit criteria in advance makes the whole thing feel less like a leap.
Starting the Conversation
Nobody has to treat menopause. Plenty of women move through it with mild symptoms and no interest in medication. That is a fair choice, not a missed chance. The problem is not that women say no. It is that many never get far enough into the talk to make a real choice.
So bring it up. Mention the three in the morning wake-ups. Mention the word you could not find in a meeting, and the joints that ache for no clear reason. Ask what your options are, including the ones with no hormones in them. If you leave the visit no better informed, ask for a referral to someone who works in menopause care often. Results vary from woman to woman. The right answer depends on your health history, your symptoms and what matters most to you. The one outcome worth avoiding is another seven years of guessing alone.
This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.
